Unsuccessful Direct Acting Antiviral Hepatitis C Treatment Among People With <scp>HIV</scp>: Findings From an International Cohort
Brendan Harney(Burnet Institute), Joseph Doyle(The Alfred Hospital), Margaret Hellard(The Alfred Hospital), Anders Boyd, Marina B. Klein(Royal Victoria Regional Health Centre), Joanne Carson(UNSW Sydney), Rachel Sacks‐Davis(Burnet Institute), Juan Berenguer(Instituto de Salud Carlos III), Colette Smit(Stichting HIV Monitoring), Ashleigh C. Stewart(Burnet Institute), Inmaculada Jarrín(Instituto de Salud Carlos III), Olivier Leleux(Université de Bordeaux), Maria Prins(University of Amsterdam), Gail Matthews(UNSW Sydney), Karine Lacombe(Inserm), Andri Rauch(University of Bern), Daniëla K. van Santen(Burnet Institute), Linda Wittkop(Université de Bordeaux), Marc van der Valk(Academic Medical Center), Laurence Merchadou
Cited by 0
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
|Nature Immunology|2022|987
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777